His primary areas of investigation include Chromatography, Designer drug, Metabolite, Gas chromatography–mass spectrometry and Forensic toxicology. His research on Chromatography frequently links to adjacent areas such as Drug. His studies deal with areas such as Amphetamine, Microsome, Glucuronidation and Hydroxylation as well as Designer drug.
His Metabolite research includes themes of Glycine, Phenylacetones and Metabolic pathway. The various areas that Hans H. Maurer examines in his Gas chromatography–mass spectrometry study include Deconvolution, Benzylpiperazine, Urine, Derivatization and Solid phase extraction. Hans H. Maurer combines subjects such as Artificial intelligence and Pattern recognition with his study of Forensic toxicology.
Hans H. Maurer mostly deals with Chromatography, Gas chromatography–mass spectrometry, Designer drug, Metabolite and Urine. His research on Chromatography often connects related topics like Drug. Hans H. Maurer interconnects Solid phase extraction, Derivatization and Piperazine in the investigation of issues within Gas chromatography–mass spectrometry.
Hans H. Maurer has researched Designer drug in several fields, including Sulfation, Glucuronidation, Metabolism and Hydroxylation. His Metabolite study integrates concerns from other disciplines, such as High-performance liquid chromatography and Stereochemistry. His research integrates issues of Amphetamine and Acid hydrolysis in his study of Urine.
The scientist’s investigation covers issues in Pharmacology, Chromatography, Forensic toxicology, Mass spectrometry and Glucuronidation. His work investigates the relationship between Pharmacology and topics such as Metabolite that intersect with problems in Designer drug. Chromatography is frequently linked to Urine in his study.
Hans H. Maurer has included themes like Drugs of abuse and Drug in his Forensic toxicology study. His studies in Mass spectrometry integrate themes in fields like Gas chromatography and Extraction. Hans H. Maurer works mostly in the field of Glucuronidation, limiting it down to topics relating to Hydroxylation and, in certain cases, Sulfation, as a part of the same area of interest.
His scientific interests lie mostly in Pharmacology, Biochemistry, Forensic toxicology, Metabolite and Tandem mass spectrometry. His work on Pharmacokinetics is typically connected to Reuptake inhibitor as part of general Pharmacology study, connecting several disciplines of science. His study in Forensic toxicology is interdisciplinary in nature, drawing from both Drugs of abuse, Drug and Distribution.
The concepts of his Metabolite study are interwoven with issues in Chromatography, Monooxygenase and Designer drug. His study in Mass spectrometry and Liquid chromatography–mass spectrometry is done as part of Chromatography. His Hydroxylation course of study focuses on Gas chromatography–mass spectrometry and Enzyme.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry
Markus R. Meyer;Jens Wilhelm;Jens Wilhelm;Frank T. Peters;Hans H. Maurer.
Analytical and Bioanalytical Chemistry (2010)
Current Role of Liquid Chromatography-Mass Spectrometry in Clinical and Forensic Toxicology
Hans H. Maurer.
Analytical and Bioanalytical Chemistry (2007)
Liquid chromatography-mass spectrometry in forensic and clinical toxicology.
Hans H. Maurer.
Journal of Chromatography B: Biomedical Sciences and Applications (1998)
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives.
Thomas Kraemer;Hans H Maurer.
Therapeutic Drug Monitoring (2002)
Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy').
Hans H Maurer;Joerg Bickeboeller-Friedrich;Thomas Kraemer;Frank T Peters.
Toxicology Letters (2000)
Systematic toxicological analysis of drugs and their metabolites by gas chromatography—mass spectrometry
Hans H. Maurer.
Journal of Chromatography B: Biomedical Sciences and Applications (1992)
Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.
Markus R. Meyer;Peng Du;Frank Schuster;Hans H. Maurer.
Journal of Mass Spectrometry (2010)
Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine
Thomas Kraemer;Hans H Maurer.
Journal of Chromatography B: Biomedical Sciences and Applications (1998)
Bioanalytical method validation and its implications for forensic and clinical toxicology – A review
Frank T. Peters;Hans H. Maurer.
Accreditation and Quality Assurance (2002)
Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology.
Hans H. Maurer.
Clinical Biochemistry (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institute on Drug Abuse
Heidelberg University
Saarland University
University of Bremen
Saarland University
Maastricht University
German Sport University Cologne
Sichuan University
University Hospital Heidelberg
Goethe University Frankfurt
McGill University
University of Michigan–Ann Arbor
Sandia National Laboratories
University of Bordeaux
Korea Institute of Science and Technology
Xiangtan University
Society for Conservation Biology Asia Section
University of Illinois at Urbana-Champaign
Queen's University
University of California, Los Angeles
Business International Corporation
University of Seville
The University of Texas at Dallas
Cincinnati Children's Hospital Medical Center
Mount Sinai Beth Israel
Universidade de São Paulo